SCA
DGX icon

Snowden Capital Advisors’s Quest Diagnostics DGX Stock Holding History

Snowden Capital Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$378K Sell
1,785
-126
-7% -$24.7K 0.01% 965
2026
Q1 		$375K Buy
1,911
+95
+5% +$18.5K 0.01% 928
2025
Q4 		$315K Buy
1,816
+200
+12% +$36.4K 0.01% 1026
2025
Q3 		$308K Sell
1,616
-77
-5% -$13.7K 0.01% 1016
2025
Q2 		$304K Sell
1,693
-76
-4% -$13.2K 0.01% 998
2025
Q1 		$299K Buy
1,769
+43
+2% +$7.06K 0.01% 977
2024
Q4 		$260K Buy
1,726
+307
+22% +$47.7K 0.01% 1050
2024
Q3 		$220K Buy
+1,419
New +$212K 0.01% 1135
2023
Q3 		– Sell
-1,431
Closed -$201K – 1081
2023
Q2 		$201K Buy
+1,431
New +$197K 0.01% 1109
2022
Q1 		– Sell
-1,097
Closed -$189K – 1288
2021
Q4 		$189K Sell
1,097
-1,863
-63% -$283K 0.01% 678
2021
Q3 		$430K Buy
2,960
+933
+46% +$137K 0.02% 571
2021
Q2 		$268K Buy
+2,027
New +$265K 0.01% 747
2020
Q3 		– Sell
-17,038
Closed -$1.94M – 578
2020
Q2 		$1.94M Buy
17,038
+5,923
+53% +$628K 0.17% 183
2020
Q1 		$893K Buy
+11,115
New +$1.15M 0.1% 256

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Snowden Capital Advisors's DGX Position: Q2 2026 in Review

Snowden Capital Advisors reduced its Quest Diagnostics (DGX) stake by 6.6% in Q2 2026, selling an estimated $24.7K and leaving 1,785 shares worth $378K. The position accounts for 0.01% of the portfolio, ranked #965.

Snowden Capital Advisors first reported a position in DGX in Q1 2020 and has held it in 14 quarters since. The position peaked at $1.94M in Q2 2020. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Snowden Capital Advisors held 1,785 shares of Quest Diagnostics worth $378K as of Q2 2026.
  • Snowden Capital Advisors sold 126 Quest Diagnostics shares in Q2 2026, an estimated $24.7K.
  • Quest Diagnostics made up 0.01% of Snowden Capital Advisors's portfolio in Q2 2026, its #965 holding.
  • Snowden Capital Advisors first reported a position in Quest Diagnostics in Q1 2020 and has held it in 14 quarters since.
  • Snowden Capital Advisors's Quest Diagnostics position peaked at $1.94M in Q2 2020.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.